Market Insights Health OTC Pharmaceuticals

Digestives & Intestinal Remedies - United States

United States

In the United States, the Digestives & Intestinal Remedies market market generates a revenue of €1.69bn in 2024.
It is projected to experience an annual growth rate of 1.83% (CAGR 2024-2029).
When compared to other countries globally, in China generates the highest revenue in this market, amounting to €4,087.00m in 2024.
Taking into account the total population, per person revenues of €4.95 are generated in the United States in 2024.
The United States is experiencing a growing demand for natural and herbal digestive remedies in the OTC Pharmaceuticals market.

Key regions: Canada, United States, Australia, Brazil, Japan

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Digestives & Intestinal Remedies market in United States is experiencing steady growth due to customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors.

Customer preferences: Customers in the United States are increasingly prioritizing their digestive health, leading to a growing demand for Digestives & Intestinal Remedies. This can be attributed to several factors such as changing lifestyles, unhealthy dietary habits, and a rising awareness about the importance of gut health. As a result, consumers are actively seeking products that can alleviate digestive issues and promote overall gut wellness.

Trends in the market: One of the key trends in the Digestives & Intestinal Remedies market in the United States is the increasing popularity of natural and herbal remedies. Consumers are becoming more conscious of the ingredients in the products they use and are opting for natural alternatives to synthetic medications. This trend is driving the demand for herbal supplements and probiotics, which are believed to have a positive impact on digestive health.Another trend in the market is the growing availability and accessibility of Digestives & Intestinal Remedies. With the rise of e-commerce platforms and online pharmacies, consumers have easier access to a wide range of products. This has expanded the market reach and allowed consumers to explore different options and brands. Additionally, the convenience of online shopping has contributed to the growth of the market.

Local special circumstances: The United States has a large aging population, which is a significant factor contributing to the growth of the Digestives & Intestinal Remedies market. Older adults are more prone to digestive issues and are actively seeking remedies to alleviate their symptoms. This demographic trend has created a strong demand for products that cater specifically to the needs of the elderly population.Furthermore, the United States has a highly developed healthcare system with a strong emphasis on preventive care. This has led to increased awareness and education about digestive health, prompting individuals to take proactive measures to maintain a healthy gut. As a result, the demand for Digestives & Intestinal Remedies has grown significantly.

Underlying macroeconomic factors: The overall economic stability and disposable income levels in the United States have also contributed to the growth of the Digestives & Intestinal Remedies market. As consumers have more purchasing power, they are willing to invest in products that can improve their overall well-being, including digestive health. The robust economy and favorable employment rates have created a conducive environment for the market to thrive.In conclusion, the Digestives & Intestinal Remedies market in the United States is experiencing steady growth due to customer preferences for digestive health, trends in the market such as the popularity of natural remedies and increased accessibility, local special circumstances such as the aging population and emphasis on preventive care, and underlying macroeconomic factors including economic stability and disposable income levels.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.